Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

NCT02673398 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

HER2 Positive Breast Carcinoma
Stage IV Breast Cancer AJCC v6 and v7

Interventions

OTHER: Comprehensive Geriatric Assessment
OTHER: Laboratory Biomarker Analysis
DRUG: Neratinib
OTHER: Pharmacological Study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]